Microbot Medical Inc.

02/27/2024 | Press release | Distributed by Public on 02/27/2024 05:04

Management Change/Compensation - Form 8-K

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On February 22, 2024, Microbot Medical Inc. (the "Company") increased the maximum annual bonus of Rachel Vaknin, its Chief Financial Officer, from a maximum of up to 25% of base salary to a maximum of up to 35% of base salary, commencing for the 2024 fiscal year. All other terms of Ms. Vaknin's compensation arrangement with the Company remain unchanged.